Related Experiment Video
Updated: Jan 7, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Bowel Transit Time May Be Accelerated in Colonic Diverticulosis Independent of Mucosal Serotonin Signaling
Piotr Nehring1, Miłosz Jastrzębski1, Ilona Joniec-Maciejak2
1Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.
Abstract:
Background/Objectives: Colonic diverticulosis is a common condition in the elderly population and may affect bowel habits and reduce quality of life. Intestinal peristalsis is regulated by bioamines, which can influence bowel transit time. Methods: This prospective, comparative study included 23 patients. All participants were examined with colonoscopy with colonic mucosal biopsy and a bowel transit time test using SITZMARKS® markers. The following bioamines were assessed in the colonic mucosa: 3-methoxy-4-hydroxyphenylglycol (MHPG), norepinephrine (NA), dopamine (DA), homovanillic acid (HVA), 5-hydroxytryptamine (5-HT, serotonin), and 5-hydroxyindoleacetic acid (5-HIAA). Results: Among study participants, 14 had colonic diverticulosis and 9 were controls. There were no differences in age, sex, body mass, or weight between the groups. All patients with diverticulosis had left-sided diverticula and a DICA score of 1. None of the patients met the diagnostic criteria outlined in the ROME IV classification of functional gastrointestinal disorders. After 48 h, patients with diverticulosis tended to retain less SITZMARKS® markers (mean of 1.14 vs. 6.78, p < 0.027), compared to the control group. Fewer patients with diverticulosis tended to have SITZMARKS® markers visible in the X-ray image at 48 h (2 out of 14 versus 4 out of 9 patients, p < 0.262), compared to the control group. There were no differences in colonic mucosal concentrations of bioamines (5-HT, 5-HIAA, MHPG, NA, DA, HVA) between cases and controls. Conclusions: Bowel transit time in patients with colonic diverticulosis may be accelerated compared with controls, and this appears unrelated to bioamine metabolism.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

